Chronic myeloid leukemia (CML), a rare myeloproliferative disease, is associated with chromosomal translocation (i.e., Philadelphia chromosome), which encodes BCR::ABL1 oncoprotein, through the fusion of BCR and ABL1 genes, with active tyrosine kinase activity (3–6). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.